Arrowhead

Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug
Johnson & Johnson pays $175M, commits to $1.6B in milestones for Arrowhead hepatitis B drug
Fierce Biotech
JNJ
Arrowhead
hepatitis B
RNAi
Flag link:
3 Biotech Stocks That Soared This Week
3 Biotech Stocks That Soared This Week
Motley Fool
ARMO BioSciences
Eli Lilly
M&A
OPKO Health
Rayaldee
Arrowhead
Flag link:
Monday’s 4 Biggest Biopharma Movers
Monday’s 4 Biggest Biopharma Movers
Yahoo/24-7 Wall St
Ariad Pharma
Arrowhead
Alcobra
Merrimack Pharmaceuticals
Flag link:
7 of the Most Shocking Biotech Pipeline Blowups of 2016
7 of the Most Shocking Biotech Pipeline Blowups of 2016
Motley Fool
biotech
Alnylam
revusiran
Clovis Oncology
rociletinib
Celldex Therapeutics
Rintega
Eli Lilly
solanezumab
Novavax
RSV-F
Arrowhead
ARC-520
ARC-521
ARC-AAT
Biomarin
drisapersen
Flag link:
Arrowhead spanked with clinical hold in hep B
Arrowhead spanked with clinical hold in hep B
BioPharma Dive
Arrowhead
ARC-520
hepatitis B
Flag link:
Amgen and Arrowhead to develop gene-therapies for heart disease
Amgen and Arrowhead to develop gene-therapies for heart disease
Yahoo/Reuters
Amgen
Arrowhead
R&D
gene therapy
heart disease
Flag link:
Arrowhead Research purchases privately held Alvos Therapeutics
Arrowhead Research purchases privately held Alvos Therapeutics
Yahoo/AP
Arrowhead
Alvos Therapeutics
M&A
Flag link:
Arrowhead unit to collaborate with Smith & Nephew
Arrowhead unit to collaborate with Smith & Nephew
Smith & Nephew
Arrowhead
cartilage regeneration
Flag link: